{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:17:29Z","timestamp":1791962249463,"version":"4.3.4"},"reference-count":97,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.mcna.2005.08.011","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T14:28:20Z","timestamp":1168439300000},"page":"17-38","source":"Crossref","is-referenced-by-count":22,"title":["Allergic Rhinitis: Impact of the Disease and Considerations for Management"],"prefix":"10.1016","volume":"90","author":[{"given":"Alexander N.","family":"Greiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2005.08.011_bib1","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1067\/mai.2001.118891","article-title":"Allergic rhinitis and its impact on asthma. ARIA workshop report","volume":"108","author":"Bousquet","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.mcna.2005.08.011_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jaci.2004.06.046","article-title":"In vitro assays for the diagnosis of IgE-mediated disorders","volume":"114","author":"Hamilton","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2005.08.011_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1542\/peds.35.1.108","article-title":"Allergic rhinitis in early infancy. Review of the literature and report of a case in a newborn","volume":"35","author":"Ingall","year":"1965","journal-title":"Pediatrics"},{"key":"10.1016\/j.mcna.2005.08.011_bib4","doi-asserted-by":"crossref","first-page":"S808","DOI":"10.1016\/S0091-6749(97)80040-1","article-title":"Prevalence of allergic rhinitis in the United States","volume":"99","author":"Nathan","year":"1997","journal-title":"J Allergy Clin Immunol"},{"issue":"6 Pt 1","key":"10.1016\/j.mcna.2005.08.011_bib5","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1542\/peds.94.6.895","article-title":"Epidemiology of physician-diagnosed allergic rhinitis in childhood","volume":"94","author":"Wright","year":"1994","journal-title":"Pediatrics"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2005.08.011_bib6","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1067\/mai.2001.115569","article-title":"Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis","volume":"108","author":"Skoner","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"5 Pt 2","key":"10.1016\/j.mcna.2005.08.011_bib7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1081-1206(10)63153-5","article-title":"Joint task force algorithm and annotations for diagnosis and management of rhinitis","volume":"81","author":"Dykewicz","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.mcna.2005.08.011_bib8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11882-001-0085-4","article-title":"Susceptibility genes in asthma and allergy","volume":"1","author":"Ober","year":"2001","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.mcna.2005.08.011_bib9","series-title":"Allergy: principles and practice","first-page":"1109","article-title":"Epidemiology and natural history of asthma, allergic rhinitis, and atopic dermatitis (eczema)","author":"Evans","year":"1993"},{"issue":"5","key":"10.1016\/j.mcna.2005.08.011_bib10","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1165\/ajrcmb.22.5.3710","article-title":"Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide","volume":"22","author":"Tulic","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.mcna.2005.08.011_bib11","series-title":"Middleton's allergy: principles and practice","first-page":"1169","article-title":"Natural history, development, and prevention of allergic disease in childhood","author":"Von Mutius","year":"2003"},{"issue":"2 Pt 1","key":"10.1016\/j.mcna.2005.08.011_bib12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0091-6749(99)70370-2","article-title":"Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey","volume":"104","author":"Leynaert","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2005.08.011_bib13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1027\/0838-1925.11.6.218","article-title":"Lessons from the French part of the European community respiratory health survey (ECRHS)","volume":"11","author":"Leynaert","year":"1999","journal-title":"Allergy Clin Immunol Int: S World Allergy Org"},{"key":"10.1016\/j.mcna.2005.08.011_bib14","unstructured":"Centers for Disease Control and Prevention. Current asthma prevalence 2002. Available at: http:\/\/www.cdc.gov. Accessed February 12, 2005."},{"key":"10.1016\/j.mcna.2005.08.011_bib15","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1164\/ajrccm.161.6.9906121","article-title":"Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients","volume":"161","author":"Braunstahl","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2005.08.011_bib16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1067\/mai.2001.113046","article-title":"Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways","volume":"107","author":"Braunstahl","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.mcna.2005.08.011_bib17","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jaci.2004.08.012","article-title":"Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi","volume":"114","author":"Shin","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2005.08.011_bib18","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1067\/mai.2000.111238","article-title":"Allergic and immunologic disorders of the eye. Part II: Ocular allergy","volume":"106","author":"Bielory","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.mcna.2005.08.011_bib19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jaci.2004.07.008","article-title":"Health-related quality of life in adult rhinitis: the role of perceived control of disease","volume":"114","author":"Chen","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"2 Pt 1","key":"10.1016\/j.mcna.2005.08.011_bib20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/ai.1994.v94.a54939","article-title":"Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire","volume":"94","author":"Bousquet","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2005.08.011_bib21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1164\/ajrccm.149.2.8306032","article-title":"Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire","volume":"149","author":"Bousquet","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"issue":"4 Pt 1","key":"10.1016\/j.mcna.2005.08.011_bib22","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1164\/ajrccm.162.4.9912033","article-title":"Quality of life in allergic rhinitis and asthma. A population-based study of young adults","volume":"162","author":"Leynaert","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.mcna.2005.08.011_bib23","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0895-4356(00)00349-8","article-title":"The work impact of asthma and rhinitis: findings from a population-based survey","volume":"54","author":"Blanc","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.mcna.2005.08.011_bib24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1056\/NEJMoa023171","article-title":"Evaluation of impermeable covers for bedding in patients with allergic rhinitis","volume":"349","author":"Terreehorst","year":"2003","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.mcna.2005.08.011_bib25","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/0091-6749(90)90050-E","article-title":"A double-blind study of the effectiveness of a high-efficiency particulate air (HEPA) filter in the treatment of patients with perennial allergic rhinitis and asthma","volume":"85","author":"Reisman","year":"1990","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.mcna.2005.08.011_bib26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1034\/j.1398-9995.2003.00100.x","article-title":"Disodium octaborate tetrahydrate (DOT) application and vacuum cleaning, a combined strategy to control house dust mites","volume":"58","author":"Codina","year":"2003","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.mcna.2005.08.011_bib27","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1046\/j.1365-2222.2000.00858.x","article-title":"A randomized trial of dehumidification in the control of house dust mite","volume":"30","author":"Hyndman","year":"2000","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.mcna.2005.08.011_bib28","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0091-6749(95)70072-2","article-title":"Cat shedding of Fel d I is not reduced by washings, Allerpet-C spray, or acepromazine","volume":"95","author":"Klucka","year":"1995","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.mcna.2005.08.011_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1164\/ajrccm.158.1.9712110","article-title":"A placebo-controlled trial of a HEPA air cleaner in the treatment of cat allergy","volume":"158","author":"Wood","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.mcna.2005.08.011_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S1081-1206(10)62324-1","article-title":"Cockroach allergen abatement with extermination and sodium hypochlorite cleaning in inner-city homes","volume":"87","author":"Wood","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.mcna.2005.08.011_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0091-6749(93)90301-U","article-title":"Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness","volume":"91","author":"Watson","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2005.08.011_bib32","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0091-6749(96)70150-1","article-title":"Once daily intranasal fluticasone propionate (200 \u03bcg) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis","volume":"98","author":"Fosi","year":"1996","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.mcna.2005.08.011_bib33","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1081-1206(10)61780-2","article-title":"Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis","volume":"92","author":"Orhan","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.mcna.2005.08.011_bib34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1398-9995.1990.tb01096.x","article-title":"Nasal inhalation of the glucocorticoid budesonide from a spacer for the treatment of patients with pollen rhinitis and asthma","volume":"45","author":"Pedersen","year":"1990","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.mcna.2005.08.011_bib35","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1067\/mai.2002.123237","article-title":"Intranasal steroids and the risk of emergency department visits for asthma","volume":"109","author":"Adams","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2005.08.011_bib36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/352497a0","article-title":"Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA","volume":"352","author":"Luisi","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.mcna.2005.08.011_bib37","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1126\/science.2119054","article-title":"Transcription factors interactions: selectors of positive or negative regulation form a single DNA element","volume":"249","author":"Diamond","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.mcna.2005.08.011_bib38","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1016\/S0091-6749(99)70310-6","article-title":"Intranasal corticosteroids for allergic rhinitis: how do different agents compare?","volume":"104","author":"Corren","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2005.08.011_bib39","first-page":"648","article-title":"Assessment by nasal biopsy of long-term use of monetasone furoate nasal spray (Nasonex) in the treatment of perennial rhinitis","volume":"118","author":"Minshall","year":"1998","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.mcna.2005.08.011_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2273.1998.00096.x","article-title":"A 1-yr placebo-controlled study of intranasal fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis: a safety and biopsy study","volume":"23","author":"Holm","year":"1998","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.mcna.2005.08.011_bib41","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0091-6749(98)70354-9","article-title":"Effect of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measurements of hypothalamic-pituitary-adrenal axis activity","volume":"101","author":"Wilson","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2005.08.011_bib42","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0091-6749(98)70275-1","article-title":"Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis","volume":"102","author":"Wilson","year":"1998","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.mcna.2005.08.011_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1164\/rccm.200305-640OC","article-title":"Inhaled and nasal corticosteroid use and the risk of fracture","volume":"169","author":"Suissa","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2005.08.011_bib44","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1365-2222.2000.00914.x","article-title":"Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis","volume":"30","author":"Van Cauwenberge","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.mcna.2005.08.011_bib45","series-title":"Histamine and H1-antihistamines in allergic disease","first-page":"141","article-title":"Clinical pharmacology of H1-antihistamines","author":"Simons","year":"2002"},{"key":"10.1016\/j.mcna.2005.08.011_bib46","first-page":"79","article-title":"Sedation from H1 antagonists: evaluation methods and experimental results","volume":"21","author":"Passalacqua","year":"1993","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.mcna.2005.08.011_bib47","first-page":"1206","article-title":"Prevalence of chlorpheniramine in aviation accident pilot fatalities, 1991\u20131996","volume":"71","author":"Soper","year":"2000","journal-title":"Aviat Space Environ Med"},{"issue":"2","key":"10.1016\/j.mcna.2005.08.011_bib48","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/(SICI)1097-0274(199608)30:2<234::AID-AJIM16>3.0.CO;2-Y","article-title":"Occupational injuries and medication use","volume":"30","author":"Gilmore","year":"1996","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.mcna.2005.08.011_bib49","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/00043764-199911000-00005","article-title":"Loss of work productivity due to illness and medical treatment","volume":"41","author":"Cockburn","year":"1999","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.mcna.2005.08.011_bib50","doi-asserted-by":"crossref","first-page":"354","DOI":"10.7326\/0003-4819-132-5-200003070-00004","article-title":"Effects of fexofenadine, diphenhydramine, and alcohol on driving performance: a randomized, placebo-controlled trial in the Iowa Driving Simulator","volume":"132","author":"Weiler","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2005.08.011_bib51","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0091-6749(89)90414-4","article-title":"Prolongation of simple and choice reaction times in a double-blinded comparison of twice-daily hydroxyzine versus terfenadine","volume":"84","author":"Goetz","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2005.08.011_bib52","series-title":"Middleton's allergy: principles and practice","first-page":"834","article-title":"H1-antihistamines","author":"Simons","year":"2003"},{"issue":"5","key":"10.1016\/j.mcna.2005.08.011_bib53","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00004714-200210000-00012","article-title":"Tolerance to daytime sedative effects of H1 antihistamines","volume":"22","author":"Richardson","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.mcna.2005.08.011_bib54","unstructured":"Zyrtec [prescribing information]. New York: Pfizer Laboratories; updated 2004. Available at: http:\/\/www.zyrtec.com. Accessed February 23, 2005."},{"key":"10.1016\/j.mcna.2005.08.011_bib55","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/j.1552-4604.1998.tb04439.x","article-title":"Brompheniramine, Loratadine and placebo in allergic rhinitis: a placebo-controlled comparative clinical trial","volume":"38","author":"Druce","year":"1998","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.mcna.2005.08.011_bib56","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2500\/105065897781751901","article-title":"Effects of anti-allergic drugs on substance P (SP) and vasoactive intestinal peptide (VIP) in nasal secretions","volume":"11","author":"Shinoda","year":"1997","journal-title":"Am J Rhinol"},{"issue":"5","key":"10.1016\/j.mcna.2005.08.011_bib57","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1081-1206(10)63465-5","article-title":"Inhibition of leukotriene synthesis by azelastine","volume":"76","author":"Hamasaki","year":"1996","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.mcna.2005.08.011_bib58","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1254\/jjp.73.145","article-title":"Suppression by azelastine hydrochloride of NF-kappa B activation involved in generation of cytokines and nitric oxide","volume":"73","author":"Yoneda","year":"1997","journal-title":"Jpn J Pharmacol"},{"issue":"6","key":"10.1016\/j.mcna.2005.08.011_bib59","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/014556139407300608","article-title":"Effectiveness of azelastine nasal solution in seasonal allergic rhinitis","volume":"73","author":"Storms","year":"1994","journal-title":"Ear Nose Throat J"},{"issue":"5","key":"10.1016\/j.mcna.2005.08.011_bib60","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/0091-6749(94)90148-1","article-title":"A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis","volume":"94","author":"Ratner","year":"1994","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.mcna.2005.08.011_bib61","first-page":"354","article-title":"Azelastine nasal spray in the management of seasonal allergic rhinitis","volume":"72","author":"Meltzer","year":"1994","journal-title":"Ann Allergy"},{"issue":"1","key":"10.1016\/j.mcna.2005.08.011_bib62","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1081-1206(10)62352-6","article-title":"Vasomotor Rhinitis Study Groups. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis","volume":"86","author":"Banov","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.mcna.2005.08.011_bib63","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/00016488309132885","article-title":"Alpha-adrenoceptor\u2013mediated secretion from the anterior nasal glands of the dog","volume":"96","author":"Malm","year":"1983","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.mcna.2005.08.011_bib64","series-title":"Allergic and non-allergic rhinitis: clinical aspects","first-page":"95","article-title":"Vasoconstrictors","author":"Malm","year":"1993"},{"key":"10.1016\/j.mcna.2005.08.011_bib65","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/2161328a0","article-title":"Disodium cromoglycate (FPL 670 \u201cIntal\u201d): a specific inhibitor of reaginic antigen\u2013antibody mechanisms","volume":"216","author":"Cos","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.mcna.2005.08.011_bib66","series-title":"Disodium cromoglycate in allergic airway disease","first-page":"33","article-title":"Protective effect of disodium cromoglycate on nasal and bronchial reactions after allergen challenge","author":"Orie","year":"1970"},{"issue":"6","key":"10.1016\/j.mcna.2005.08.011_bib67","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0149-2918(02)80009-1","article-title":"NasalCrom Study Group. Efficacy and patient satisfaction with cromolyn sodium nasal solution in the treatment of seasonal allergic rhinitis: a placebo-controlled study","volume":"24","author":"Meltzer","year":"2002","journal-title":"Clin Ther"},{"issue":"1 Pt 2","key":"10.1016\/j.mcna.2005.08.011_bib68","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0091-6749(76)90147-0","article-title":"Treatment of perennial allergic rhinitis with cromolyn sodium. Double-blind study on 34 adult patients","volume":"58","author":"Cohan","year":"1976","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl","key":"10.1016\/j.mcna.2005.08.011_bib69","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1007\/BF02484433","article-title":"Concentrations of chemical mediators in nasal secretions after nasal allergen challenges in atopic patients","volume":"252","author":"Wang","year":"1995","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.mcna.2005.08.011_bib70","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2222.1986.tb01960.x","article-title":"Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretions in humans","volume":"16","author":"Bisgaard","year":"1986","journal-title":"Clin Allergy"},{"issue":"3","key":"10.1016\/j.mcna.2005.08.011_bib71","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0014-2999(99)00037-0","article-title":"Involvement of cysteinyl leukotrienes in biphasic increase of nasal airway resistance of antigen-induced rhinitis in guinea pigs","volume":"369","author":"Fujita","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mcna.2005.08.011_bib72","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0140-6736(95)12297-4","article-title":"Zileuton","volume":"348","author":"McGill","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2005.08.011_bib73","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1164\/ajrccm.152.3.7663802","article-title":"Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma","volume":"152","author":"Wenzel","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2005.08.011_bib74","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0091-6749(96)80002-9","article-title":"Acute and chronic effects of a %-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial","volume":"98","author":"Liu","year":"1996","journal-title":"J Allergy Clin Immunol"},{"issue":"25","key":"10.1016\/j.mcna.2005.08.011_bib75","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1056\/NEJM199012203232506","article-title":"Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor","volume":"323","author":"Knapp","year":"1990","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.mcna.2005.08.011_bib76","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1164\/ajrccm.159.6.9810016","article-title":"Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis","volume":"159","author":"Pullerits","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.mcna.2005.08.011_bib77","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S1081-1206(10)62228-4","article-title":"Effects of zafirlukast upon clinical, physiologic, and inflammatory responses to natural cat allergen exposure","volume":"87","author":"Corren","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.mcna.2005.08.011_bib78","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1067\/mai.2000.105123","article-title":"A randomized, double-blind, placebo-controlled trial of the effect of zafirlukast on upper and lower respiratory responses to cat challenge","volume":"105","author":"Phipatanakul","year":"2000","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.mcna.2005.08.011_bib79","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1046\/j.1365-2222.2002.01422.x","article-title":"Montelukast Spring Rhinitis Study Group. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring","volume":"32","author":"Philip","year":"2002","journal-title":"Clin Exp Allergy"},{"issue":"12","key":"10.1016\/j.mcna.2005.08.011_bib80","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1046\/j.1398-9995.2003.00261.x","article-title":"Montelukast Fall Rhinitis Study Group. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period","volume":"58","author":"van Adelsberg","year":"2003","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.mcna.2005.08.011_bib81","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1081-1206(10)61576-1","article-title":"Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies","volume":"92","author":"Chervinsky","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.mcna.2005.08.011_bib82","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1067\/mai.2000.106040","article-title":"Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial","volume":"105","author":"Meltzer","year":"2000","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.mcna.2005.08.011_bib83","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.0022-0477.2001.01252.x","article-title":"A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis","volume":"32","author":"Wilson","year":"2002","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"10.1016\/j.mcna.2005.08.011_bib84","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S1081-1206(10)61847-9","article-title":"Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast","volume":"90","author":"Ratner","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.mcna.2005.08.011_bib85","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1164\/ajrccm.164.supplement_1.2103023","article-title":"Anti-IgE (Omalizumab) therapy in seasonal allergic rhinitis","volume":"164","author":"Casale","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2005.08.011_bib86","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1067\/mai.2000.108310","article-title":"Recombinant humanized mAb-E25, an anti IgE mAb, in birch pollen\u2013induced seasonal allergic rhinitis","volume":"106","author":"Adelroth","year":"2000","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.mcna.2005.08.011_bib87","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1081-1206(10)62171-0","article-title":"Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis","volume":"91","author":"Chervinsky","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"10.1016\/j.mcna.2005.08.011_bib88","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1398-9995.2004.00550.x","article-title":"Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR","volume":"59","author":"Vignola","year":"2004","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.mcna.2005.08.011_bib89","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1081-1206(10)61495-0","article-title":"Effects of omalizumab, a humanized monoclonal anti IgE antibody, on nasal reactivity to allergen and local IgE synthesis","volume":"93","author":"Corren","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.mcna.2005.08.011_bib90","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jaci.2004.03.024","article-title":"Mechanisms of immunotherapy","volume":"113","author":"Till","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"1 Suppl. 1","key":"10.1016\/j.mcna.2005.08.011_bib91","first-page":"1","article-title":"Allergen immunotherapy: a practice parameter. American Academy of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology","volume":"90","author":"Joint Task Force on Practice Parameters","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"10.1016\/j.mcna.2005.08.011_bib92","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199908123410702","article-title":"Long-term clinical efficacy of grass-pollen immunotherapy","volume":"341","author":"Durham","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.mcna.2005.08.011_bib93","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1067\/mai.2001.112027","article-title":"Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial","volume":"107","author":"Walker","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.mcna.2005.08.011_bib94","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1046\/j.1365-2222.2003.01735.x","article-title":"Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial","volume":"33","author":"Varney","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.mcna.2005.08.011_bib95","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1067\/mai.2002.121317","article-title":"Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis","volume":"109","author":"M\u00f6ller","year":"2002","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.mcna.2005.08.011_bib96","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jaci.2004.02.006","article-title":"Immunotherapy Committee, American Academy of Allergy, Asthma and Immunology. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990\u20132001","volume":"113","author":"Bernstein","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2005.08.011_bib97","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0889-8561(05)70154-5","article-title":"Immunotherapy for allergic rhinitis","volume":"20","author":"Li","year":"2000","journal-title":"Immunol Allergy Clin North Am"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712505000945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712505000945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T09:44:07Z","timestamp":1683711847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712505000945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0025712505000945"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2005.08.011","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}